These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2480854)

  • 21. Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia.
    Momparler RL; Momparler LF; Samson J
    Leuk Res; 1984; 8(6):1043-9. PubMed ID: 6083417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-beta-D-arabinofuranosylcytosine.
    Rahman YE; Patel KR; Cerny EA; Maccoss M
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1105-12. PubMed ID: 6540691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
    Grem JL; Allegra CJ
    Cancer Res; 1990 Nov; 50(22):7279-84. PubMed ID: 1699659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical pharmacology and DNA methylation studies of arabinosyl 5-azacytidine and 5,6-dihydro-5-azacytidine in two human leukemia cell lines PER-145 and PER-163.
    Kees UR; Avramis VI
    Anticancer Drugs; 1995 Apr; 6(2):303-10. PubMed ID: 7540895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.
    Nihei Y; Suga Y; Morinaga Y; Ohishi K; Okano A; Ohsumi K; Hatanaka T; Nakagawa R; Tsuji T; Akiyama Y; Saito S; Hori K; Sato Y; Tsuruo T
    Jpn J Cancer Res; 1999 Sep; 90(9):1016-25. PubMed ID: 10551333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.
    Veselý J; Pískala A
    Neoplasma; 1986; 33(1):3-10. PubMed ID: 2421173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).
    Townsend A; Leclerc JM; Dutschman G; Cooney D; Cheng YC
    Cancer Res; 1985 Aug; 45(8):3522-8. PubMed ID: 2410096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
    Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
    Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of 4'-thio-beta-D-arabinofuranosylcytosine (4'-thio-ara-C) and comparison of its anticancer activity with that of ara-C.
    Tiwari KN; Shortnacy-Fowler AT; Cappellacci L; Parker WB; Waud WR; Montgomery JA; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):329-40. PubMed ID: 10772718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.
    Richel DJ; Colly LP; Lurvink E; Willemze R
    Br J Cancer; 1988 Dec; 58(6):730-3. PubMed ID: 2465015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.
    Ahluwalia GS; Cohen MB; Kang GJ; Arnold ST; McMahon JB; Dalal M; Wilson YA; Cooney DA; Balzarini J; Johns DG
    Cancer Res; 1986 Sep; 46(9):4479-85. PubMed ID: 2425954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity on murine tumors of a novel antitumor benzoylphenylurea derivative, HO-221.
    Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Fujimoto S; Tsukagoshi S; Taguchi T
    Cancer Chemother Pharmacol; 1991; 28(5):351-6. PubMed ID: 1914078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
    Breistøl K; Balzarini J; Sandvold ML; Myhren F; Martinsen M; De Clercq E; Fodstad O
    Cancer Res; 1999 Jun; 59(12):2944-9. PubMed ID: 10383159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
    Jarvis WD; Povirk LF; Turner AJ; Traylor RS; Gewirtz DA; Pettit GR; Grant S
    Biochem Pharmacol; 1994 Mar; 47(5):839-52. PubMed ID: 8135859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts.
    Kirstein MN; Houghton PJ; Cheshire PJ; Richmond LB; Smith AK; Hanna SK; Stewart CF
    Clin Cancer Res; 2001 Feb; 7(2):358-66. PubMed ID: 11234891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro pharmacodynamics of 1-beta-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II).
    Kern DH; Morgan CR; Hildebrand-Zanki SU
    Cancer Res; 1988 Jan; 48(1):117-21. PubMed ID: 3334986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
    Parker WB; Shaddix SC; Gilbert KS; Shepherd RV; Waud WR
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):253-61. PubMed ID: 19002461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.